SpringWorks Therapeutics Operating Margin vs. Shares Owned By Insiders

SWTX Stock  USD 42.31  0.24  0.56%   
Based on SpringWorks Therapeutics' profitability indicators, SpringWorks Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess SpringWorks Therapeutics' ability to earn profits and add value for shareholders.

SpringWorks Therapeutics Operating Profit Margin

(66.12)

At this time, SpringWorks Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. EV To Sales is likely to rise to 411.56 in 2024, whereas Days Sales Outstanding is likely to drop 317.90 in 2024. At this time, SpringWorks Therapeutics' Accumulated Other Comprehensive Income is fairly stable compared to the past year. Interest Income is likely to rise to about 23.3 M in 2024, despite the fact that Operating Income is likely to grow to (325.9 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.960.9225
Sufficiently Up
Slightly volatile
For SpringWorks Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SpringWorks Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SpringWorks Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SpringWorks Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SpringWorks Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out World Market Map.
For more information on how to buy SpringWorks Stock please use our How to Invest in SpringWorks Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of SpringWorks Therapeutics. If investors know SpringWorks will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about SpringWorks Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.89)
Revenue Per Share
1.885
Return On Assets
(0.34)
Return On Equity
(0.59)
The market value of SpringWorks Therapeutics is measured differently than its book value, which is the value of SpringWorks that is recorded on the company's balance sheet. Investors also form their own opinion of SpringWorks Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is SpringWorks Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because SpringWorks Therapeutics' market value can be influenced by many factors that don't directly affect SpringWorks Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between SpringWorks Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if SpringWorks Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, SpringWorks Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

SpringWorks Therapeutics Shares Owned By Insiders vs. Operating Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining SpringWorks Therapeutics's current stock value. Our valuation model uses many indicators to compare SpringWorks Therapeutics value to that of its competitors to determine the firm's financial worth.
SpringWorks Therapeutics is rated fifth in operating margin category among its peers. It is rated below average in shares owned by insiders category among its peers . At this time, SpringWorks Therapeutics' Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SpringWorks Therapeutics' earnings, one of the primary drivers of an investment's value.

SpringWorks Shares Owned By Insiders vs. Operating Margin

Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

SpringWorks Therapeutics

Operating Margin

 = 

Operating Income

Revenue

X

100

 = 
(1.18) %
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

SpringWorks Therapeutics

Insiders Shares

 = 

Executives Shares

+

Employees

 = 
2.01 %
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.

SpringWorks Shares Owned By Insiders Comparison

SpringWorks Therapeutics is currently under evaluation in shares owned by insiders category among its peers.

SpringWorks Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in SpringWorks Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, SpringWorks Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of SpringWorks Therapeutics' change in net profit over the period of time. It can combine multiple indicators of SpringWorks Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income1.2 M1.3 M
Operating Income-343 M-325.9 M
Income Tax Expense-22.9 M-21.8 M
Income Before Tax-325.1 M-308.8 M
Net Loss-249.7 M-237.2 M
Net Loss-325.1 M-308.8 M
Interest Income22.1 M23.3 M
Net Loss-305 M-289.7 M
Total Other Income Expense Net17.9 M18.8 M
Net Interest Income22.1 M23.3 M
Change To Netincome88.5 M93 M
Net Loss(5.15)(5.41)
Income Quality 0.69  0.55 
Net Income Per E B T 0.89  0.78 

SpringWorks Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on SpringWorks Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SpringWorks Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SpringWorks Therapeutics' important profitability drivers and their relationship over time.

Use SpringWorks Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SpringWorks Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SpringWorks Therapeutics will appreciate offsetting losses from the drop in the long position's value.

SpringWorks Therapeutics Pair Trading

SpringWorks Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to SpringWorks Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SpringWorks Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SpringWorks Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SpringWorks Therapeutics to buy it.
The correlation of SpringWorks Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SpringWorks Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SpringWorks Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SpringWorks Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your SpringWorks Therapeutics position

In addition to having SpringWorks Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Size And Style ETFs Thematic Idea Now

Size And Style ETFs
Size And Style ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Size And Style ETFs theme has 1094 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Size And Style ETFs Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for SpringWorks Stock Analysis

When running SpringWorks Therapeutics' price analysis, check to measure SpringWorks Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SpringWorks Therapeutics is operating at the current time. Most of SpringWorks Therapeutics' value examination focuses on studying past and present price action to predict the probability of SpringWorks Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SpringWorks Therapeutics' price. Additionally, you may evaluate how the addition of SpringWorks Therapeutics to your portfolios can decrease your overall portfolio volatility.